THE BARE STORY
Lotte Biologics held a completion ceremony on Nov. 18 for the first plant at its Songdo Bio Campus in Incheon, South Korea.
The plant has a production capacity of 120,000 liters. The company is developing the site for contract biopharmaceutical manufacturing.
Lotte Group Chairman Shin Dong-bin, who attended the ceremony, described the bio sector as a future growth engine for the group. Company officials said the Incheon plant would operate alongside Lotte Biologics’ manufacturing facility in Syracuse, New York.
Note: All TheBareNews content is AI-generated. For additional context, reporting, and updates, you are invited to explore the news outlets linked above.